Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Virios Therapeutics, Llc (VIRI)  
$0.35 0.02 (4.75%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 8,280,000
Market Cap: 2.94(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.3124 - $2.42
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Virios Therapeutics is a development-stage biotechnology company, which engages in the improvement of antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia. Co.'s primary candidate, IMC-1, is a proprietary, fixed dose combination of famciclovir and celecoxib. IMC-1 represents a combination, dual mechanism antiviral therapy designed to synergistically suppress herpes virus activation and replication, with the end goal of reducing viral mediated disease burden.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 40,335 64,026
Total Buy Value $0 $0 $51,237 $156,549
Total People Bought 0 0 2 4
Total Buy Transactions 0 0 2 7
Total Shares Sold 0 0 0 1,800
Total Sell Value $0 $0 $0 $466
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 1
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 30
  Page 2 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Duncan Gregory Scott Chief Executive Officer   •       •      –    2021-01-06 4 OE $7.80 $6,248 D/D 801 3,904     -
   Pridgen William Director   –       •      –    2020-12-17 4 B $11.98 $17,970 D/D 1,500 727,192 2.39     -
   Keefer David R Director   –       •      –    2020-12-16 3 IO $0.00 $0 I/I 0 6,206     -
   Duncan Gregory Scott Chief Executive OfficerOfficer   •       •      –    2020-12-16 3 IO $0.00 $0 D/D 0 3,103     -
   Pridgen William Director   –       •      –    2020-12-16 3 IO $0.00 $0 D/D 0 725,692     -

  30 Records found
  1  2    
  Page 2 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed